MGX
Metagenomi Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$1.475
Máximo
$1.475
Mínimo
$1.475
Volume
0.25M
Fundamentos da empresa
Estatísticas de negociação
Notícias relacionadas
Chardan Capital Maintains Buy on Metagenomi, Lowers Price Target to $12
Chardan Capital analyst Geulah Livshits maintains Metagenomi with a Buy and lowers the price target from $13 to $12.
Wells Fargo Maintains Overweight on Metagenomi, Lowers Price Target to $16
Wells Fargo analyst Yanan Zhu maintains Metagenomi with a Overweight and lowers the price target from $20 to $16.
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
- Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - Advancements demonstrate
Metagenomi to Present at Upcoming Scientific Meetings
EMERYVILLE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (NASDAQ:MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing
Ações relacionadas
PMVP
PMV Pharmaceuticals Inc.
BRAC
Broad Capital Acquisition Corp
VOC
VOC Energy Trust Units of Beneficial Interest
PRS
Prudential Financial Inc. 5.625% Junior Subordinated Notes due 2058
MSAI
MultiSensor AI Holdings Inc.
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.